GO:0034080 | CENP-A containing nucleosome assembly | 8.18e-04 | 1.00e+00 | 5.539 | 2 | 2 | 20 |
GO:0036053 | glomerular endothelium fenestra | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0035759 | mesangial cell-matrix adhesion | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0004832 | valine-tRNA ligase activity | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0071971 | extracellular vesicular exosome assembly | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0043199 | sulfate binding | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:1900038 | negative regulation of cellular response to hypoxia | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:1900035 | negative regulation of cellular response to heat | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:1900168 | positive regulation of glial cell line-derived neurotrophic factor secretion | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0072254 | metanephric glomerular mesangial cell differentiation | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 1 |
GO:0000775 | chromosome, centromeric region | 3.43e-03 | 1.00e+00 | 4.504 | 2 | 6 | 41 |
GO:1900041 | negative regulation of interleukin-2 secretion | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:2000781 | positive regulation of double-strand break repair | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0019865 | immunoglobulin binding | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0071657 | positive regulation of granulocyte colony-stimulating factor production | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0038001 | paracrine signaling | 4.30e-03 | 1.00e+00 | 7.861 | 1 | 1 | 2 |
GO:0006334 | nucleosome assembly | 5.27e-03 | 1.00e+00 | 4.189 | 2 | 4 | 51 |
GO:0072011 | glomerular endothelium development | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 3 |
GO:0061042 | vascular wound healing | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 3 |
GO:0006563 | L-serine metabolic process | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 3 |
GO:0071636 | positive regulation of transforming growth factor beta production | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 3 |
GO:0030485 | smooth muscle contractile fiber | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 3 |
GO:0048251 | elastic fiber assembly | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 1 | 4 |
GO:0033093 | Weibel-Palade body | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 1 | 4 |
GO:0005654 | nucleoplasm | 8.58e-03 | 1.00e+00 | 1.671 | 6 | 68 | 876 |
GO:0045292 | mRNA cis splicing, via spliceosome | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 2 | 4 |
GO:0006564 | L-serine biosynthetic process | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 1 | 4 |
GO:0007599 | hemostasis | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 1 | 4 |
GO:0071156 | regulation of cell cycle arrest | 8.58e-03 | 1.00e+00 | 6.861 | 1 | 2 | 4 |
GO:0001889 | liver development | 1.00e-02 | 1.00e+00 | 3.711 | 2 | 4 | 71 |
GO:0072089 | stem cell proliferation | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0042482 | positive regulation of odontogenesis | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0060290 | transdifferentiation | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0005859 | muscle myosin complex | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0090344 | negative regulation of cell aging | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0003158 | endothelium development | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0009117 | nucleotide metabolic process | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 5 |
GO:0005739 | mitochondrion | 1.13e-02 | 1.00e+00 | 1.819 | 5 | 32 | 659 |
GO:0045766 | positive regulation of angiogenesis | 1.20e-02 | 1.00e+00 | 3.576 | 2 | 4 | 78 |
GO:0050847 | progesterone receptor signaling pathway | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 6 |
GO:0048739 | cardiac muscle fiber development | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 6 |
GO:0032982 | myosin filament | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 6 |
GO:0046578 | regulation of Ras protein signal transduction | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 4 | 7 |
GO:0000339 | RNA cap binding | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 7 |
GO:0051382 | kinetochore assembly | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 2 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 2 | 7 |
GO:2001214 | positive regulation of vasculogenesis | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 2 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 4 | 7 |
GO:0005845 | mRNA cap binding complex | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0030195 | negative regulation of blood coagulation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0071425 | hematopoietic stem cell proliferation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 4 | 8 |
GO:0003094 | glomerular filtration | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0031091 | platelet alpha granule | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 8 |
GO:0006379 | mRNA cleavage | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 9 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 9 |
GO:0010225 | response to UV-C | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 2 | 9 |
GO:0032039 | integrator complex | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 9 |
GO:0006939 | smooth muscle contraction | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 10 |
GO:0008334 | histone mRNA metabolic process | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 11 |
GO:0001935 | endothelial cell proliferation | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 11 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 2 | 11 |
GO:0008408 | 3'-5' exonuclease activity | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 11 |
GO:0007049 | cell cycle | 2.50e-02 | 1.00e+00 | 3.016 | 2 | 8 | 115 |
GO:0000132 | establishment of mitotic spindle orientation | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 12 |
GO:0001894 | tissue homeostasis | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 12 |
GO:0005829 | cytosol | 2.64e-02 | 1.00e+00 | 1.058 | 8 | 88 | 1787 |
GO:0007597 | blood coagulation, intrinsic pathway | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 2 | 13 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 1 | 13 |
GO:0032733 | positive regulation of interleukin-10 production | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 2 | 13 |
GO:0031589 | cell-substrate adhesion | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 1 | 13 |
GO:0000278 | mitotic cell cycle | 2.85e-02 | 1.00e+00 | 2.151 | 3 | 28 | 314 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 2 | 14 |
GO:0009897 | external side of plasma membrane | 3.18e-02 | 1.00e+00 | 2.828 | 2 | 3 | 131 |
GO:0048870 | cell motility | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 1 | 15 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 16 |
GO:0031667 | response to nutrient levels | 3.60e-02 | 1.00e+00 | 4.774 | 1 | 2 | 17 |
GO:0044212 | transcription regulatory region DNA binding | 3.73e-02 | 1.00e+00 | 2.701 | 2 | 13 | 143 |
GO:0031047 | gene silencing by RNA | 3.80e-02 | 1.00e+00 | 4.691 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 3.80e-02 | 1.00e+00 | 4.691 | 1 | 1 | 18 |
GO:0006913 | nucleocytoplasmic transport | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 20 |
GO:1901215 | negative regulation of neuron death | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 20 |
GO:0032720 | negative regulation of tumor necrosis factor production | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 20 |
GO:0034660 | ncRNA metabolic process | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 20 |
GO:0071897 | DNA biosynthetic process | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 20 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 2 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 4 | 22 |
GO:0008307 | structural constituent of muscle | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 2 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 1 | 22 |
GO:0045171 | intercellular bridge | 4.84e-02 | 1.00e+00 | 4.338 | 1 | 1 | 23 |
GO:0009925 | basal plasma membrane | 4.84e-02 | 1.00e+00 | 4.338 | 1 | 1 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 6 | 24 |
GO:0009267 | cellular response to starvation | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 1 | 26 |
GO:0005057 | receptor signaling protein activity | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 2 | 26 |
GO:0001890 | placenta development | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 2 | 26 |
GO:0004842 | ubiquitin-protein transferase activity | 5.59e-02 | 1.00e+00 | 2.377 | 2 | 17 | 179 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.06e-02 | 1.00e+00 | 4.003 | 1 | 4 | 29 |
GO:0003774 | motor activity | 6.06e-02 | 1.00e+00 | 4.003 | 1 | 1 | 29 |
GO:0006446 | regulation of translational initiation | 6.06e-02 | 1.00e+00 | 4.003 | 1 | 2 | 29 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.47e-02 | 1.00e+00 | 3.907 | 1 | 6 | 31 |
GO:0045111 | intermediate filament cytoskeleton | 6.47e-02 | 1.00e+00 | 3.907 | 1 | 3 | 31 |
GO:0006281 | DNA repair | 6.97e-02 | 1.00e+00 | 2.196 | 2 | 24 | 203 |
GO:0000786 | nucleosome | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 1 | 34 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 7.21e-02 | 1.00e+00 | 1.613 | 3 | 29 | 456 |
GO:0031093 | platelet alpha granule lumen | 7.27e-02 | 1.00e+00 | 3.732 | 1 | 3 | 35 |
GO:0031124 | mRNA 3'-end processing | 7.27e-02 | 1.00e+00 | 3.732 | 1 | 4 | 35 |
GO:0044297 | cell body | 7.27e-02 | 1.00e+00 | 3.732 | 1 | 5 | 35 |
GO:0050434 | positive regulation of viral transcription | 7.27e-02 | 1.00e+00 | 3.732 | 1 | 5 | 35 |
GO:0003743 | translation initiation factor activity | 7.67e-02 | 1.00e+00 | 3.652 | 1 | 8 | 37 |
GO:0001948 | glycoprotein binding | 7.67e-02 | 1.00e+00 | 3.652 | 1 | 1 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 5 | 38 |
GO:0009611 | response to wounding | 8.46e-02 | 1.00e+00 | 3.504 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 8.46e-02 | 1.00e+00 | 3.504 | 1 | 1 | 41 |
GO:0005737 | cytoplasm | 8.51e-02 | 1.00e+00 | 0.669 | 9 | 127 | 2633 |
GO:0008217 | regulation of blood pressure | 8.66e-02 | 1.00e+00 | 3.469 | 1 | 2 | 42 |
GO:0000724 | double-strand break repair via homologous recombination | 8.66e-02 | 1.00e+00 | 3.469 | 1 | 5 | 42 |
GO:0001938 | positive regulation of endothelial cell proliferation | 8.86e-02 | 1.00e+00 | 3.435 | 1 | 1 | 43 |
GO:0006406 | mRNA export from nucleus | 9.06e-02 | 1.00e+00 | 3.402 | 1 | 7 | 44 |
GO:0008283 | cell proliferation | 9.24e-02 | 1.00e+00 | 1.960 | 2 | 8 | 239 |
GO:0051087 | chaperone binding | 9.25e-02 | 1.00e+00 | 3.369 | 1 | 3 | 45 |
GO:0001570 | vasculogenesis | 9.25e-02 | 1.00e+00 | 3.369 | 1 | 2 | 45 |
GO:0009612 | response to mechanical stimulus | 9.45e-02 | 1.00e+00 | 3.338 | 1 | 2 | 46 |
GO:0001725 | stress fiber | 9.45e-02 | 1.00e+00 | 3.338 | 1 | 6 | 46 |
GO:0005518 | collagen binding | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 2 | 47 |
GO:0000502 | proteasome complex | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 3 | 47 |
GO:0003723 | RNA binding | 9.77e-02 | 1.00e+00 | 1.913 | 2 | 22 | 247 |
GO:0030097 | hemopoiesis | 9.84e-02 | 1.00e+00 | 3.276 | 1 | 3 | 48 |
GO:0005758 | mitochondrial intermembrane space | 9.84e-02 | 1.00e+00 | 3.276 | 1 | 4 | 48 |
GO:0001558 | regulation of cell growth | 1.00e-01 | 1.00e+00 | 3.246 | 1 | 2 | 49 |
GO:0002020 | protease binding | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 3 | 50 |
GO:0010467 | gene expression | 1.05e-01 | 1.00e+00 | 1.383 | 3 | 49 | 535 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.06e-01 | 1.00e+00 | 3.161 | 1 | 8 | 52 |
GO:0006936 | muscle contraction | 1.10e-01 | 1.00e+00 | 3.106 | 1 | 5 | 54 |
GO:0005730 | nucleolus | 1.11e-01 | 1.00e+00 | 0.934 | 5 | 74 | 1217 |
GO:0050776 | regulation of immune response | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 2 | 55 |
GO:0016311 | dephosphorylation | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 3 | 55 |
GO:0008584 | male gonad development | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 5 | 58 |
GO:0006464 | cellular protein modification process | 1.23e-01 | 1.00e+00 | 2.930 | 1 | 4 | 61 |
GO:0005515 | protein binding | 1.23e-01 | 1.00e+00 | 0.436 | 12 | 198 | 4124 |
GO:0002576 | platelet degranulation | 1.25e-01 | 1.00e+00 | 2.907 | 1 | 3 | 62 |
GO:0016337 | single organismal cell-cell adhesion | 1.25e-01 | 1.00e+00 | 2.907 | 1 | 3 | 62 |
GO:0010629 | negative regulation of gene expression | 1.25e-01 | 1.00e+00 | 2.907 | 1 | 1 | 62 |
GO:0051015 | actin filament binding | 1.27e-01 | 1.00e+00 | 2.884 | 1 | 2 | 63 |
GO:0030018 | Z disc | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 3 | 64 |
GO:0042470 | melanosome | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 3 | 64 |
GO:0047485 | protein N-terminus binding | 1.31e-01 | 1.00e+00 | 2.839 | 1 | 6 | 65 |
GO:0003676 | nucleic acid binding | 1.33e-01 | 1.00e+00 | 2.817 | 1 | 4 | 66 |
GO:0005178 | integrin binding | 1.37e-01 | 1.00e+00 | 2.774 | 1 | 3 | 68 |
GO:0051082 | unfolded protein binding | 1.40e-01 | 1.00e+00 | 2.732 | 1 | 5 | 70 |
GO:0030308 | negative regulation of cell growth | 1.40e-01 | 1.00e+00 | 2.732 | 1 | 3 | 70 |
GO:0007165 | signal transduction | 1.44e-01 | 1.00e+00 | 1.175 | 3 | 24 | 618 |
GO:0051726 | regulation of cell cycle | 1.46e-01 | 1.00e+00 | 2.671 | 1 | 3 | 73 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.47e-01 | 1.00e+00 | 1.553 | 2 | 17 | 317 |
GO:0001649 | osteoblast differentiation | 1.48e-01 | 1.00e+00 | 2.652 | 1 | 5 | 74 |
GO:0030246 | carbohydrate binding | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 1 | 80 |
GO:0042127 | regulation of cell proliferation | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 4 | 80 |
GO:0030529 | ribonucleoprotein complex | 1.62e-01 | 1.00e+00 | 2.504 | 1 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.66e-01 | 1.00e+00 | 2.469 | 1 | 5 | 84 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.66e-01 | 1.00e+00 | 1.447 | 2 | 23 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 1.68e-01 | 1.00e+00 | 1.435 | 2 | 11 | 344 |
GO:0051260 | protein homooligomerization | 1.71e-01 | 1.00e+00 | 2.418 | 1 | 2 | 87 |
GO:0044267 | cellular protein metabolic process | 1.74e-01 | 1.00e+00 | 1.402 | 2 | 14 | 352 |
GO:0042802 | identical protein binding | 1.76e-01 | 1.00e+00 | 1.393 | 2 | 15 | 354 |
GO:0050900 | leukocyte migration | 1.79e-01 | 1.00e+00 | 2.353 | 1 | 2 | 91 |
GO:0000209 | protein polyubiquitination | 1.80e-01 | 1.00e+00 | 2.338 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.80e-01 | 1.00e+00 | 2.338 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.84e-01 | 1.00e+00 | 2.306 | 1 | 9 | 94 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.89e-01 | 1.00e+00 | 2.261 | 1 | 7 | 97 |
GO:0006457 | protein folding | 1.89e-01 | 1.00e+00 | 2.261 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.93e-01 | 1.00e+00 | 2.232 | 1 | 6 | 99 |
GO:0005516 | calmodulin binding | 1.93e-01 | 1.00e+00 | 2.232 | 1 | 4 | 99 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.94e-01 | 1.00e+00 | 1.303 | 2 | 21 | 377 |
GO:0005764 | lysosome | 1.95e-01 | 1.00e+00 | 2.217 | 1 | 2 | 100 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.03e-01 | 1.00e+00 | 2.147 | 1 | 5 | 105 |
GO:0010628 | positive regulation of gene expression | 2.05e-01 | 1.00e+00 | 2.133 | 1 | 2 | 106 |
GO:0031012 | extracellular matrix | 2.07e-01 | 1.00e+00 | 2.120 | 1 | 4 | 107 |
GO:0042981 | regulation of apoptotic process | 2.15e-01 | 1.00e+00 | 2.054 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 2.17e-01 | 1.00e+00 | 2.041 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 2.20e-01 | 1.00e+00 | 2.016 | 1 | 4 | 115 |
GO:0005578 | proteinaceous extracellular matrix | 2.20e-01 | 1.00e+00 | 2.016 | 1 | 4 | 115 |
GO:0042803 | protein homodimerization activity | 2.34e-01 | 1.00e+00 | 1.120 | 2 | 13 | 428 |
GO:0016032 | viral process | 2.34e-01 | 1.00e+00 | 1.120 | 2 | 30 | 428 |
GO:0005634 | nucleus | 2.37e-01 | 1.00e+00 | 0.367 | 9 | 158 | 3246 |
GO:0000398 | mRNA splicing, via spliceosome | 2.42e-01 | 1.00e+00 | 1.861 | 1 | 15 | 128 |
GO:0005759 | mitochondrial matrix | 2.60e-01 | 1.00e+00 | 1.742 | 1 | 7 | 139 |
GO:0030168 | platelet activation | 2.63e-01 | 1.00e+00 | 1.722 | 1 | 5 | 141 |
GO:0016874 | ligase activity | 2.71e-01 | 1.00e+00 | 1.671 | 1 | 11 | 146 |
GO:0016324 | apical plasma membrane | 2.73e-01 | 1.00e+00 | 1.661 | 1 | 2 | 147 |
GO:0001701 | in utero embryonic development | 2.84e-01 | 1.00e+00 | 1.594 | 1 | 7 | 154 |
GO:0005874 | microtubule | 2.98e-01 | 1.00e+00 | 1.512 | 1 | 10 | 163 |
GO:0005524 | ATP binding | 3.00e-01 | 1.00e+00 | 0.645 | 3 | 37 | 892 |
GO:0008380 | RNA splicing | 3.01e-01 | 1.00e+00 | 1.495 | 1 | 21 | 165 |
GO:0016071 | mRNA metabolic process | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 10 | 170 |
GO:0006412 | translation | 3.21e-01 | 1.00e+00 | 1.385 | 1 | 12 | 178 |
GO:0046872 | metal ion binding | 3.26e-01 | 1.00e+00 | 0.579 | 3 | 24 | 934 |
GO:0008152 | metabolic process | 3.27e-01 | 1.00e+00 | 1.353 | 1 | 6 | 182 |
GO:0003677 | DNA binding | 3.33e-01 | 1.00e+00 | 0.559 | 3 | 52 | 947 |
GO:0016567 | protein ubiquitination | 3.35e-01 | 1.00e+00 | 1.306 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 3.35e-01 | 1.00e+00 | 1.306 | 1 | 10 | 188 |
GO:0005743 | mitochondrial inner membrane | 3.48e-01 | 1.00e+00 | 1.239 | 1 | 9 | 197 |
GO:0035556 | intracellular signal transduction | 3.51e-01 | 1.00e+00 | 1.224 | 1 | 5 | 199 |
GO:0005887 | integral component of plasma membrane | 3.53e-01 | 1.00e+00 | 0.694 | 2 | 8 | 575 |
GO:0008134 | transcription factor binding | 3.65e-01 | 1.00e+00 | 1.154 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 3.67e-01 | 1.00e+00 | 1.147 | 1 | 7 | 210 |
GO:0030198 | extracellular matrix organization | 3.82e-01 | 1.00e+00 | 1.073 | 1 | 7 | 221 |
GO:0019901 | protein kinase binding | 3.97e-01 | 1.00e+00 | 1.003 | 1 | 8 | 232 |
GO:0007411 | axon guidance | 4.03e-01 | 1.00e+00 | 0.972 | 1 | 8 | 237 |
GO:0007155 | cell adhesion | 4.13e-01 | 1.00e+00 | 0.930 | 1 | 8 | 244 |
GO:0003682 | chromatin binding | 4.23e-01 | 1.00e+00 | 0.884 | 1 | 15 | 252 |
GO:0046982 | protein heterodimerization activity | 4.39e-01 | 1.00e+00 | 0.811 | 1 | 11 | 265 |
GO:0043565 | sequence-specific DNA binding | 4.51e-01 | 1.00e+00 | 0.758 | 1 | 8 | 275 |
GO:0008285 | negative regulation of cell proliferation | 4.54e-01 | 1.00e+00 | 0.747 | 1 | 11 | 277 |
GO:0008284 | positive regulation of cell proliferation | 4.56e-01 | 1.00e+00 | 0.737 | 1 | 8 | 279 |
GO:0005925 | focal adhesion | 4.60e-01 | 1.00e+00 | 0.722 | 1 | 14 | 282 |
GO:0006355 | regulation of transcription, DNA-templated | 4.62e-01 | 1.00e+00 | 0.379 | 2 | 31 | 715 |
GO:0070062 | extracellular vesicular exosome | 4.80e-01 | 1.00e+00 | 0.181 | 4 | 51 | 1641 |
GO:0044822 | poly(A) RNA binding | 5.22e-01 | 1.00e+00 | 0.219 | 2 | 45 | 799 |
GO:0007596 | blood coagulation | 5.24e-01 | 1.00e+00 | 0.456 | 1 | 13 | 339 |
GO:0005509 | calcium ion binding | 5.37e-01 | 1.00e+00 | 0.406 | 1 | 9 | 351 |
GO:0005783 | endoplasmic reticulum | 5.67e-01 | 1.00e+00 | 0.287 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 5.95e-01 | 1.00e+00 | 0.178 | 1 | 15 | 411 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.25e-01 | 1.00e+00 | -0.324 | 1 | 22 | 582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.62e-01 | 1.00e+00 | -0.470 | 1 | 29 | 644 |
GO:0005576 | extracellular region | 7.72e-01 | 1.00e+00 | -0.512 | 1 | 15 | 663 |
GO:0008270 | zinc ion binding | 8.03e-01 | 1.00e+00 | -0.645 | 1 | 39 | 727 |
GO:0044281 | small molecule metabolic process | 8.50e-01 | 1.00e+00 | -0.860 | 1 | 35 | 844 |
GO:0006351 | transcription, DNA-templated | 9.14e-01 | 1.00e+00 | -1.210 | 1 | 47 | 1076 |
GO:0005886 | plasma membrane | 9.18e-01 | 1.00e+00 | -0.940 | 2 | 46 | 1784 |
GO:0016020 | membrane | 9.38e-01 | 1.00e+00 | -1.376 | 1 | 56 | 1207 |